The Department of Health has announced that a new vaccine will replace the HPV vaccine.Girls (aged 12-13) will now receive a vaccine which will protect them against cervical cancer and genital warts.
The new vaccine 'Gardasil' will replace 'Cervarix', a cheaper vaccine used from 2008. Both jabs protect against Human Papilloma virus (HPV) types 16 & 18 which cause over 70% of cervical cancer cases. Gardasil also protects against types 6 & 11 which cause genital warts. It is thought that we may be able to significantly reduce the prevalence of this sexually transmitted infection as well as preventing 400 deaths from cervical cancer.
This article shows how healthcare is forever changing both in terms of technology and funding. It has now become economically viable to change to a more expensive vaccine in order to provide people with further protection.
No comments:
Post a Comment